CAPLIN POINT LABORATORIES LTD.

SectorHealthcare
Promoter GroupPrivate
CMP ()889.90 -5.35 (-0.6 %)  
Chairman C C Paarthipan
Industry Pharmaceuticals & Drugs
Managing Director Sridhar Ganesan
52 WK LOW / HIGH () 4021034
Market Cap ( In Cr.) 6,731.45
Incorporation Year 1990
P/E Ratio39.88

Registered Office

Address Not Available
Phone Not Available
Email Not Available
Website Not Available

price chart AS ON 04 NOV 2020

1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Price/Earning (TTM)35.06
TTM EPS ( ) 22.31
Book Value ( ) 105.55
Price/Sales (TTM) 13.72
Price/Book (MRQ) 8.43
Face Value ( )2
Dividend Yield(%)0.34
PAT Margin (%)32.37
ROCE (%) 30.92
ROE (%) 23.42

SHAREHOLDING PATTERN

PROMOTERS
69.03%
NON-INSTITUTION
28.34%
MUTUAL FUNDS/UTI
0.99%
FI/BANKS/INSURANCE
0.45%
GOVERNMENT
0%
FII
0%

STOCK CAGR RETURNS

CAGR Returns % 1 Month 3 Months 6 Months 1 Year 2 Years 3 Years 5 Years
Caplin Point Laboratories Ltd.19.1034.24114.6961.3245.0827.2427.35
SENSEX7.3413.4623.9660.6124.7417.8916.24
BSE5007.6712.0426.4965.9727.6917.8815.35
*Return less than & equal to 1 year absolute and more than 1 year are CAGR

CAPLIN POINT LABORATORIES LTD. QUARTERLY RESULTS

() In Crores Jun 2021(Q2)Mar 2021(Q1)Qtr-On-Qtr Growth %Jun 2020(Q2)Year-On-Year Growth %
Sales300.44278.711.57%240.0829.49%
Net Profit715.30679.202.69%545.5039.01%
Operating Profit1018.20951.506.02%780.9029.56%
OPM %33.89%34.14%-32.53%-
EPS in ()9.378.77-7.21-
Sales127.5122.88-0.23%119.7322.73%
Net Profit545.50314.90-24.08%420.20-37.18%
Operating Profit756.40506.40-16.93%615.00-29.20%
OPM %59.33%41.21%-51.37%-
EPS in ()7.214.16-5.55-

CAPLIN POINT LABORATORIES LTD. FINANCIAL PERFORMANCE OVER YEARS

() In Crores Mar-17Mar-18Mar-19Mar-20Mar-21TTM
Sales401.65539.84648.69863.21061.29490.46
Sales %68.2534.4120.1633.0722.95-
Operating Profit134.76207.98250.88301.4352.18246.7
OPM %33.5538.5338.6834.9233.1850.3
PAT95.5144.64176.56215.08251.43168.78
EPS in ()12.6519.1523.3428.4232.0322.31
Sales341.55426.57536.91527.83482.68490.46
Sales %68.2534.4120.1633.0722.95-
Operating Profit106.34165.56224272.96232.54246.7
OPM %31.1338.8141.7251.7148.1850.3
PAT70.32102.31148.17197.64156.22168.78
EPS in ()9.313.5319.5926.1320.6522.31

DISCLAIMER

ValueMulticaps is registered with SEBI (Research Analyst) Regulations 2014, Registration No. INH000005829 is an Independent Equity Advisory Firm.
Use of the information herein is at one's own risk. This is not an offer to sell or solicit to buy any securities and ValueMulticaps will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual investors. Before acting on any recommendation, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek independent professional advice. All content and information is provided on an 'As Is' basis by ValueMulticaps . Information herein is believed to be reliable but ValueMulticaps does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. As a condition to accessing ValueMulticaps content and website, you agree to our Terms and Conditions of Use. The performance data quoted represents past performance and does not guarantee future results.